IP Library › Granted Patent US 7,858,643
Granted Patent B2
US 7,858,643 · App. 11/212,331 · Granted Dec 28, 2010

Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,643
App. No.
11/212,331
Granted
Dec 28, 2010
Kind
B2
Abstract

Enantiomerically pure compound of formula 1 are provided, as well as methods for their synthesis and use. Preferred compounds are potent inhibitors of the c-Met protein kinase, and are useful in the treatment of abnormal cell growth disorders, such as cancers.

Claims (3)

1. A compound of the formula:

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

Assignments (3)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2013
From: AGOURON PHARMACEUTICALS, INC.
To: PFIZER INC.
Reel/Frame 030542/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: CUI, JINGRONG JEAN; FUNK, LEE ANDREW; JIA, LEI; KUNG, PEI-PEI; MENG, JERRY JIALUN; NAMBU, MITCHELL DAVID; PAIRISH, MASON ALAN; SHEN, HONG; TRAN-DUBE, MICHELLE
To: AGOURON PHARMACEUTICALS, INC.
Reel/Frame 030536/0193 →